Upgrade to SI Premium - Free Trial

CVS's (CVS) OptumRx Win Belies Risk - Evercore ISI

November 29, 2016 10:01 AM
Evercore ISI analyst Ross Muken was positive on CVS Health (NYSE: CVS) after the company OptumRx (UNH) announced that they ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments

Next Articles